Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Long-lasting symptoms like fatigue and breathlessness can persist after COVID-19, requiring ongoing medical follow-up.

About 61% of women who had COVID-19 experienced hair loss afterward.

Cepharanthine shows promise as a COVID-19 treatment.

Teledermatology was popular among young adults and women, and high-resolution photos improved service during the pandemic.

Androgenic alopecia is linked to more severe COVID-19 and higher mortality.

Teledermatology effectively managed most skin conditions remotely during the COVID-19 pandemic.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

The COVID-19 pandemic led to fewer dermatology visits, older and more male patients, and more stress-related skin issues.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Your lifestyle and health can affect your chances of getting COVID-19; not enough sleep, lots of exercise, and hair loss can increase risk, while washing hands, eating fruit daily, and taking vitamins A and C can lower it.

Recent research on androgenetic alopecia focuses on optimizing treatments, with promising new therapies emerging.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

People with androgenetic alopecia may have a higher risk of severe COVID-19.

A woman's complete hair loss condition improved after recovering from COVID-19.

People with androgenetic alopecia had milder COVID-19 symptoms during the Omicron wave in China.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Alopecia patients in Hebei, China, have poor knowledge and negative attitudes but take proactive steps to manage the condition.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

COVID-19 can cause various skin issues, including rashes and 'COVID toes', and may worsen autoimmune diseases or affect men with baldness more severely.

COVID-19 can cause hair and nail disorders after infection.

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Dermatologists helped identify COVID-19 through skin symptoms and managed skin issues during the pandemic, but more high-quality research is needed.